or
forgot password

    • cancer clinical trials in san bernardino, CA

    • Efficacy Study of ABR-215050 to Treat Prostate Cancer
    San Bernardino Urological Associates
    San Bernardino, California
    Prostate Cancer
    PRostate Cancer Individual Signature Evaluation Trial in Patients Undergoing Scheduled Prostate Biopsy
    San Bernardino Urological Associates
    San Bernardino, California
    Prostate Cancer
    Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Docetaxel and Prednisone (CRPC)
    San Bernardino Urological Associates
    San Bernardino, California
    Castrate-Resistant Prostate Cancer
    Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
    San Bernardino Urological Assoc.
    San Bernardino, California 92404
    Prostate Cancer
    A 2 Part Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer
    San Bernardino Urological Associates
    San Bernardino, California
    Prostate Cancer
    Clinical Trial in Males With BPH (Enlarged Prostate)
    San Bernardino Urology Associates
    San Bernardino, California 92404
    Urinary Retention, Prostatic Hyperplasia, Benign Prostatic Hypertrophy
    YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy
    San Bernardino Urological Associates
    San Bernardino, California
    Hormone-Refractory Prostate Cancer, Prostatic Neoplasms
    MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer
    San Bernardino Urological Associates
    San Bernardino, California
    Prostate Cancer
    Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)
    San Bernardino Urological Associates Medical Group
    San Bernardino, California 92404
    Preneoplastic Conditions, Prostatic Intraepithelial Neoplasia
    Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients
    San Bernardino Urological Associates Medical Group
    San Bernardino, California 92404
    Prostate Cancer
    Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486
    San Bernardino Urological Associates Medical Group
    San Bernardino, California 92404
    Prostate Cancer
    Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients
    San Bernardino Urology Associates
    San Bernardino, California 92404
    Prostate Cancer
    A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer
    San Bernardino Urological Associates
    San Bernardino, California
    Prostate Cancer, Prostatic Neoplasms, Cancer of the Prostate
    Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer
    Sanofi-Aventis Investigational Site Number 840005
    San Bernardino, California 92404
    Urinary Bladder Neoplasms
    A Study of Degarelix in Patients With Prostate Cancer
    San Bernardino Urological Associates
    San Bernardino, California
    Prostate Cancer
    ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer
    San Bernardino Urological Associates
    San Bernardino, California
    Prostate Cancer
    TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)
    San Bernardino Urology
    San Bernardino, California 92404
    Hormone Refractory Prostate Cancer